Radiation recall dermatitis induced by mogamulizumab

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e107-e108. doi: 10.1111/jdv.16033. Epub 2019 Nov 19.

Authors

K Sasaki¹, S Iinuma¹, M Fujii¹, T Shibuya¹, K Kanno¹, M Honma¹, M Hatayama², A Ishida-Yamamoto¹

Affiliations

¹ Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
² Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.

PMID: 31660660
DOI: 10.1111/jdv.16033

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents / adverse effects*
Humans
Male
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy*
Radiodermatitis / chemically induced*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
mogamulizumab